Brief: Charmacy Pharmaceutical Posts FY Net Profit Attributable Of RMB45.43 Mln
March 26 (Reuters) - Charmacy Pharmaceutical Co Ltd
2289.HK :
* FY OPERATING REVENUE RMB3,935.25 MILLION, DOWN 3.92%
* BOARD RECOMMENDS DISTRIBUTION OF A FINAL DIVIDEND OF
RMB0.30 PER
SHARE
* FY GROUP NET PROFIT ATTRIBUTABLE RMB45.43 MILLION, UP
1.50%
Source text for Eikon: ID:nHKS8yMG4Y
Further company coverage: 2289.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Charmacy Pharmaceutical Co
See all newsBrief: Charmacy Pharmaceutical Sees Decrease In Net Profit Attributable By 45% For Year
Brief: Charmacy Pharmaceutical Says Yao Chuanglong Ceased To Be Chairman
Brief: Charmacy Pharmaceutical Posts FY Operating Revenue RMB4,175.28 Million
Brief: Charmacy Pharmaceutical Says Controlling Shareholder To Provide Loan Facility
Brief: Charmacy Pharmaceutical Says Applied For Trading Resumption From Feb 17